Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease

Completed

Conditions studied: Breast Cancer, Hodgkin's Disease

In brief

The purpose of this study is to determine if the use of breast MRI in detecting breast malignancies in survivors of Hodgkin's disease is more successful than the traditional mammogram.

Key facts

Study ID

NCT00165412

Run by

Dana-Farber Cancer Institute

People needed

148

Starts

2005-07-01

Expected to finish

2010-05-01

Last updated by the study team

2019-05-02

Who can join

Age: 20 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female patients treated with radiation therapy to the chest area for Hodgkin's disease
• Age between 12 and 35 at initial treatment
• Eight years or longer after initial treatment
• Pre-approval from the participant's insurance company for the breast imaging studies

You may not qualify if…

• Pregnant or lactating women
• Post Bilateral mastectomy
• Currently undergoing breast cancer therapy
• Known metastatic cancer
• Patients with contraindications for undergoing an MRI: cardiac pacemaker, known metallic objects in body e.g. metallic clips, bullets, shrapnel or buckshots.

Where it is running

• Brigham and Women's Hospital — Boston, Massachusetts, United States
• Dana-Farber Cancer Center — Boston, Massachusetts, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.